Saturday, June 13, 2026

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Chinese Academy of clinical programs — 1328 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Intelligence · Clinical Programs

Chinese Academy of projects

1,328 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 18 of 28
  1. 30% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis

    approved small molecule completed

    1 trial
  2. 30%Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis, Postoperative

    approved small molecule completed

    1 trial
  3. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial
  4. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial
  5. 80% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxygenation Index

    approved small molecule active

    1 trial
  6. ACEI / ARB+finerenone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Henoch Schönlein Purpura Nephritis

    approved small molecule active

    1 trial
  7. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial
  8. Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial
  9. Alendronate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteogenesis Imperfecta

    approved small molecule completed

    1 trial
  10. Anerning particle

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Community-acquired Pneumonia

    approved small molecule active

    1 trial
  11. Anshen Buxin Liuwei Pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiac Neurosis

    approved small molecule active

    1 trial
  12. Anti-Platelet Drugs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    3 trials
  13. Aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Coronary Syndrome

    approved small molecule active

    1 trial
  14. Aspirin + Clopidogrel + Rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule active

    1 trial
  15. Atomoxetine 80mg combined with oxybutynin 5mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obstructive Sleep Apnea of Adult

    approved small molecule completed

    1 trial
  16. Berberine plus lifestyle intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    approved small molecule completed

    1 trial
  17. Bisoprolol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    approved small molecule completed

    1 trial
  18. Bortezomib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Waldenström Macroglobulinemia

    approved small molecule completed

    1 trial
  19. Brivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Herpes Zoster

    approved small molecule active

    1 trial
  20. Brucea javanica oil emulsion injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved other active

    1 trial
  21. Budesonide-Surfactant

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Infants

    approved small molecule terminated

    1 trial
  22. CAPA001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial
  23. COVAX

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    1 trial
  24. Camrelizumab + chemotherapy+Thalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule active

    1 trial
  25. Chinese Herb Huang-Chi-Wu-Wu-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracranial Arterial Stenosis

    approved small molecule active

    1 trial
  26. Chloroprocaine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    approved small molecule completed

    1 trial
  27. Cinacalcet HCl

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperparathyroidism; Secondary, Renal

    approved small molecule completed

    1 trial
  28. Citrate anticoagulation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial
  29. Clopidogrel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial
  30. Colchicine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    In-stent Restenosis

    approved small molecule active

    1 trial
  31. Colla corii asini

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thalassemia

    approved small molecule active

    1 trial
  32. Colquhounia Root Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  33. Conventional therapy + S (+)-Ketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    S-ketamine

    approved small molecule active

    1 trial
  34. Covid-19 vaccine (0-1-4 schedule)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    2 trials
  35. Cytokine-induced killer cells+ FOLFOX4

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved small molecule completed

    1 trial
  36. Danlou Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial
  37. Daratumumab and corticosteroid treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Hemophilia

    approved small molecule active

    1 trial
  38. De-escalated Dual Antiplatelet Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial
  39. Dexamethasone and N-acetylcysteine (NAC)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial
  40. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lower Limb Fracture

    approved small molecule completed

    1 trial
  41. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thoracic Paravertebral Blocks

    approved small molecule terminated

    1 trial
  42. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Post-Surgical Pain

    approved small molecule active

    1 trial
  43. Dexmedetomidine Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule completed

    1 trial
  44. Dexmedetomidine Injectable Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    approved small molecule completed

    1 trial
  45. Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial
  46. EUS-guided pancreatic pseudocyst drainage

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Pseudocyst

    approved other active

    1 trial
  47. EV71 Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial
  48. Echocardiographic guidance

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aortic Stenosis

    approved other active

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.